The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Don't forget we were at 50p for some weeks last summer, but without the shops being open currently, this sp doesn't look sustainable in the short term to me, but long term we should return to 150p+ in a few years, assuming the new CEO proves to be the right man for the job (I'm not 100% convinced).
I'm holding and will buy more when the opportunity arises, which it will.
CARD clearly needs some new thinking and direction, and I'm not yet convinced that employing someone with history in the industry is the correct approach. Time will tell, but it's time CARD has not got on its side. I can see the potential for a shareholder revolt here.
Thank you Rox for your input.
I am a very frustrated CARD investor. There is such potential, but I am utterly bemused by the total lack of action by the current board to wake up and smell the coffee.
Some will take a profit and exit this share, others will take the view that the SP is ahead of itself and take a profit with a view to buying back on a drop.
Some will say the current SP is being fuelled by speculation and others will say it's being fuelled by people's expectation of a positive report on 25th Feb.
I've been holding since April 2020, and I haven't been tempted to take a profit yet.